Related Experiment Video
Updated: Jul 13, 2025

08:04
In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
11.7K
Genetic Basis of Relapse after GPRC5D-Targeted CAR T Cells
Xiaoli Mi1, Alex Penson1, Omar Abdel-Wahab1
1Memorial Sloan Kettering Cancer Center, New York, NY mailanks@mskcc.org.
The New England Journal of Medicine
|October 11, 2023
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Tumor Immunotherapy
539
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
539

